Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

L. J. Wirth, E. Sherman, B. Robinson, B. Solomon, H. Kang, J. Lorch, F. Worden, M. Brose, J. Patel, S. Leboulleux, Y. Godbert, F. Barlesi, J. C. Morris, T. K. Owonikoko, D. S.W. Tan, O. Gautschi, J. Weiss, C. De La Fouchardière, M. E. Burkard, J. LaskinM. H. Taylor, M. Kroiss, J. Medioni, J. W. Goldman, T. M. Bauer, B. Levy, V. W. Zhu, N. Lakhani, V. Moreno, K. Ebata, M. Nguyen, D. Heirich, E. Y. Zhu, X. Huang, L. Yang, J. Kherani, S. M. Rothenberg, A. Drilon, V. Subbiah, M. H. Shah, M. E. Cabanillas, L. J. Wirth

Research output: Contribution to journalArticlepeer-review

389 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of Selpercatinib in RET-Altered Thyroid Cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences